Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Sofosbuvir, velpatasvir, and voxilaprevir
Determining the interaction of Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Sofosbuvir, velpatasvir, and voxilaprevir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: sofosbuvir / velpatasvir / voxilaprevir
Brand name: Vosevi
Synonyms: Sofosbuvir, Velpatasvir, and Voxilaprevir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Sojourn
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Sojourn Inhalant
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Solage
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Solage Topical
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Solaice
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Solaice Patch
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant [Pegylated])
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant) (Advate)
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant) (Afstyla)
- Sofosbuvir, velpatasvir, and voxilaprevir-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)